CO2022011987A2 - Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol - Google Patents

Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol

Info

Publication number
CO2022011987A2
CO2022011987A2 CONC2022/0011987A CO2022011987A CO2022011987A2 CO 2022011987 A2 CO2022011987 A2 CO 2022011987A2 CO 2022011987 A CO2022011987 A CO 2022011987A CO 2022011987 A2 CO2022011987 A2 CO 2022011987A2
Authority
CO
Colombia
Prior art keywords
hydroxytyrosol
polyphenols
compositions
hydroxytyrol
improve
Prior art date
Application number
CONC2022/0011987A
Other languages
English (en)
Inventor
Hortigüela Óscar Bañuelos
Rojo Ruth Blanco
Lobón José Antonio Maldonado
Martínez Luis Pérez
Larramendi José Luis López
Martín Mónica María Olivares
Original Assignee
Biosearch S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch S A filed Critical Biosearch S A
Publication of CO2022011987A2 publication Critical patent/CO2022011987A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a composiciones de origen natural, que comprenden hidroxitirosol y polifenoles que no son hidroxitirosol y que no se encuentran de forma natural en el olivo (O. europaea), caracterizadas por permitir una biodisponibilidad particularmente alta de hidroxitirosol y una actividad antiaterosclerótica particularmente alta de hidroxitirosol, una vez administrado por vía oral. Dichas composiciones pueden consistir en mezclas de extractos vegetales. La invención también se refiere al uso de dichas composiciones para el tratamiento de enfermedades cardiovasculares, en particular la aterosclerosis.
CONC2022/0011987A 2020-02-28 2022-08-23 Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol CO2022011987A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES2020070147 2020-02-28
PCT/EP2021/054840 WO2021170806A1 (en) 2020-02-28 2021-02-26 Uses and compositions based on polyphenols for improving the oral bioavailability of hydroxytyrosol

Publications (1)

Publication Number Publication Date
CO2022011987A2 true CO2022011987A2 (es) 2022-09-09

Family

ID=70471066

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0011987A CO2022011987A2 (es) 2020-02-28 2022-08-23 Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol

Country Status (10)

Country Link
EP (1) EP4110309A1 (es)
JP (1) JP2023514680A (es)
KR (1) KR20220123074A (es)
CN (1) CN115003291A (es)
AU (1) AU2021228197A1 (es)
BR (1) BR112022015705A2 (es)
CO (1) CO2022011987A2 (es)
MX (1) MX2022010216A (es)
TW (1) TWI795736B (es)
WO (1) WO2021170806A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
US6258846B1 (en) 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7112609B2 (en) 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
ES2288123B1 (es) * 2006-06-05 2008-10-01 Furfural Español, S.A. Composicion alimentaria funcional rica en compuestos fenolicos y uso de dicha composicion.
WO2008006581A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
MX2010000832A (es) * 2007-07-23 2010-07-06 Probelte Pharma S A Enriquecimiento de productos nutricionales con extractos de oliva conteniendo hidroxitirosol y productos nutricionales enriquecidos con hidroxitirosol.
FR2942224B1 (fr) * 2009-02-18 2012-11-30 Centre De Cooperation Internationale En Rech Agronomique Pour Le Developpement Cirad Procede d'extraction de composes phenoliques a partir d'eau de vegetation de l'olive et preparation d'extrait titre en polyphenols d'olive et de raisin
ES2592210T3 (es) * 2009-04-17 2016-11-28 Dsm Ip Assets B.V. Combinaciones de hidroxitirosol para mejorar la función mitocondrial y producción de energía
EP2338500A1 (en) * 2009-12-23 2011-06-29 Phenofarm S.r.l. Process for producing concentrated and refined actives from tissues and byproducts of Olea europaea with membrane technologies
EP3003338A1 (en) * 2013-05-29 2016-04-13 Nestec S.A. Compositions for use in cartilage breakdown
WO2015006651A1 (en) * 2013-07-11 2015-01-15 Specialty Nutrition Group, Inc. Compositions comprising hydroxytyrosol, resveratrol, lycopene, flavanols, and/or flavonoids and use thereof
RU2016107746A (ru) * 2013-08-09 2017-09-11 Сантори Холдингз Лимитед Средство, способствующее абсорбции гидрокситирозола и его производных in vivo, и применение такого средства

Also Published As

Publication number Publication date
TWI795736B (zh) 2023-03-11
AU2021228197A1 (en) 2022-07-07
WO2021170806A1 (en) 2021-09-02
EP4110309A1 (en) 2023-01-04
BR112022015705A2 (pt) 2022-09-27
JP2023514680A (ja) 2023-04-07
KR20220123074A (ko) 2022-09-05
MX2022010216A (es) 2022-09-19
CN115003291A (zh) 2022-09-02
TW202131912A (zh) 2021-09-01

Similar Documents

Publication Publication Date Title
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
NI201700101A (es) Composiciones farmacéuticas que comprenden n - (3, 5 - dimetoxifenil) - n'- (1-metiletil) - n - [3-(1-metil-1h-pirazol-4-il) quinoxalina-6-il]etano-1,2-diamina
CO2020015156A2 (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos referencia cruzada a una solicitud relacionada
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CL2018003302A1 (es) Uso de prg4 como agente antiinflamatorio. (divisional solicitud 201701893).
AR107871A1 (es) Combinaciones de inhibidores de lsd1 para su uso en el tratamiento de tumores sólidos
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
CO2018012258A2 (es) Compuestos de mic-1 y usos de estos
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
AR101236A1 (es) Composiciones para el cuidado oral
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
CO2019006652A2 (es) Amidas aromáticas de ácidos carboxílicos como antagonistas del receptor de bradiquinina b1
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
CO2022011987A2 (es) Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol
CO2019007671A2 (es) Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer
CL2022003507A1 (es) Composición y método para tratar el dolor crónico
MY186286A (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
CO2018011686A2 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant
CO2022000211A2 (es) Composiciones farmacéuticas resistentes a la descarga de dosis que comprenden venirunad
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
ES2422423T3 (es) Usos cosméticos y farmacéuticos de un extracto de las semillas de Buchholzia coriacea
AR109199A1 (es) Composición y uso de un péptido
AR108792A1 (es) Composiciones que comprenden timolol
AR065918A1 (es) Composiciones farmaceuticas sinergicas que comprenden la combinacion de un inhibidor de la enzina 5 alfa-reductasa y un antagonista de los receptores 1-adrenergicos